LifeVantage Corp LFVN:NASDAQ (Common Stock)

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
1.17 0.01   0.86% 1,019,532408.0K
Market data is delayed by at least 20 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Previous close 10/8/2014

Latest News Headlines for LifeVantage Corp

Video Release -- LifeVantage Launches Two Multi-Dimensional Energy Products in the United States

Video Release -- LifeVantage Launches Two Multi-Dimensional Energy Products in the United States Company Introduces New Approach to Energy Drink Market SALT LAKE CITY, Oct. 3, 2014 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), has entered the exciting new energy product category that will forever change how exhausted, over-stressed people around the world regain their edge. Unlike other one-dimensional energy products that rely almost entirely on caffeine and sugar for a temporary energy boost, both LifeVantage energy drink powders deliver sustained energy, as well as improved mental focus and promote a positive mood. All derived from a unique combination of scientifically validated ingredients.

View more recent headlines

Latest Annual and Quarterly SEC Filings

More Filings
10-K

This report contains detailed information about the company's business finances and management.

10-Q

Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)

Company Background

Lifevantage Corporation (Lifevantage) is engaged in the identification, research, development, manufacture and distribution of advanced nutraceutical dietary supplements, including its product, Protandim, the Nrf2 Synergizer and its anti-aging skin care product, LifeVantage TrueScience. The Company focuses its ongoing internal research efforts on oxidative stress solutions, particularly the activation of nuclear factor (erythroid-derived 2)-like 2, also known as Nrf2, as it relates to health-related disorders. The Company provides products and network marketing business opportunity to customers and independent distributors. The Company sells its products in the United States, Japan, Australia and Mexico through a network of independent distributors, and to preferred and retail customers. In April 2014, the Company acquired a line of sports nutrition products known as Wicked Fast Sports Nutrition.

http://www.lifevantage.com

Loading...

collapse, right-facing arrow indicating collapsed view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open1.18
Previous Close1.17
Day High--
Day Low--
52 Week High10/25/2013 | 2.62
52 Week Low1/31/2014 | 1.10
% Off 52 Week High-55.34%
% Off 52 Week Low6.36%
Beta (5 Yr)0.81
Volatility Avg10/8/2014 | 49.64
10-Day Avg. Volume408,048
Market data is delayed by at least 20 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)6/30/2014 | 0.10
P/E Ratio6/30/2014 | 11.5
Market CapMicro Cap | 118.0M
Shares Outstanding100.82M
Float97.9M

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield--
Ex-Date--
Dividend Announcement--
Date of Record--
Payable-- - --
Payable Date--

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short1.79M
Short Ratio3.9
Short % of Float1.87%
As of 9/15/2014

Peers Information HelpLFVN LifeVantage Corp vs. Peers

Peers 
LFVN
LifeVantage Corp
-29.09%
Johnson & Johnson
14.54%
Prestige Brands Holdings, Inc.
-11.73%
Pfizer Inc.
-4.08%
Merck & Co., Inc.
20.24%
LFVN
LifeVantage Corp
0.00%
Johnson & Johnson
2.67%
Prestige Brands Holdings, Inc.
--
Pfizer Inc.
3.54%
Merck & Co., Inc.
2.92%
LFVN
LifeVantage Corp
0.86%
Johnson & Johnson
2.46%
Prestige Brands Holdings, Inc.
0.57%
Pfizer Inc.
2.05%
Merck & Co., Inc.
2.94%
Compare these stocks